Literature DB >> 33248804

Lack of evidence for association of UQCRC1 with Parkinson's disease in Europeans.

Konstantin Senkevich1, Sara Bandres-Ciga2, Ziv Gan-Or3, Lynne Krohn4.   

Abstract

Recently, a novel variant p.Y314S in UQCRC1 has been implicated as pathogenic in Parkinson's disease (PD). In the present study, we aimed to examine the association of UQCRC1 with PD in large cohorts of European origin. We examined common and rare genetic variation in UQCRC1 using genome-wide association study data from the International Parkinson Disease Genomics Consortium, including 14,671 cases and 17,667 controls, and whole-genome sequencing data from the Accelerating Medicines Partnership-Parkinson's disease initiative, including 1647 patients with PD and 1050 controls. No common variants were consistently associated with PD, and a variety of burden analyses did not reveal an association between rare variants in UQCRC1 and PD. Therefore, our results do not support a major role for UQCRC1 in PD in the European population, and additional studies in other populations are warranted.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Genetics; Parkinson disease; UQCRC1

Mesh:

Substances:

Year:  2020        PMID: 33248804      PMCID: PMC8938960          DOI: 10.1016/j.neurobiolaging.2020.10.030

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  16 in total

1.  DNAJ mutations are rare in Chinese Parkinson's disease patients and controls.

Authors:  Jia Nee Foo; Herty Liany; Louis C Tan; Wing-Lok Au; Kumar-M Prakash; Jianjun Liu; Eng-King Tan
Journal:  Neurobiol Aging       Date:  2013-10-12       Impact factor: 4.673

Review 2.  'Atypical' Parkinson's disease - genetic.

Authors:  Anne Weissbach; Christina Wittke; Meike Kasten; Christine Klein
Journal:  Int Rev Neurobiol       Date:  2019-11-25       Impact factor: 3.230

Review 3.  Genetics of Parkinson's disease: An introspection of its journey towards precision medicine.

Authors:  Sara Bandres-Ciga; Monica Diez-Fairen; Jonggeol Jeff Kim; Andrew B Singleton
Journal:  Neurobiol Dis       Date:  2020-01-25       Impact factor: 5.996

Review 4.  The EIF4G1 gene and Parkinson's disease.

Authors:  H Deng; Y Wu; J Jankovic
Journal:  Acta Neurol Scand       Date:  2015-03-13       Impact factor: 3.209

5.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data.

Authors:  Kai Wang; Mingyao Li; Hakon Hakonarson
Journal:  Nucleic Acids Res       Date:  2010-07-03       Impact factor: 16.971

6.  Critical role of UQCRC1 in embryo survival, brain ischemic tolerance and normal cognition in mice.

Authors:  Weiran Shan; Jun Li; Wenhao Xu; Hong Li; Zhiyi Zuo
Journal:  Cell Mol Life Sci       Date:  2019-01-21       Impact factor: 9.261

7.  A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease.

Authors:  Rejko Krüger; Manu Sharma; Olaf Riess; Thomas Gasser; Christine Van Broeckhoven; Jessie Theuns; Jan Aasly; Grazia Annesi; Anna Rita Bentivoglio; Alexis Brice; Ana Djarmati; Alexis Elbaz; Matthew Farrer; Carlo Ferrarese; J Mark Gibson; Georgios M Hadjigeorgiou; Nobutaka Hattori; John P A Ioannidis; Barbara Jasinska-Myga; Christine Klein; Jean-Charles Lambert; Suzanne Lesage; Juei-Jueng Lin; Timothy Lynch; George D Mellick; Francesa de Nigris; Grzegorz Opala; Alessandro Prigione; Aldo Quattrone; Owen A Ross; Wataru Satake; Peter A Silburn; Eng King Tan; Tatsushi Toda; Hiroyuki Tomiyama; Karin Wirdefeldt; Zbigniew Wszolek; Georgia Xiromerisiou; Demetrius M Maraganore
Journal:  Neurobiol Aging       Date:  2009-12-24       Impact factor: 4.673

8.  Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies.

Authors:  Mike A Nalls; Cornelis Blauwendraat; Costanza L Vallerga; Karl Heilbron; Sara Bandres-Ciga; Diana Chang; Manuela Tan; Demis A Kia; Alastair J Noyce; Angli Xue; Jose Bras; Emily Young; Rainer von Coelln; Javier Simón-Sánchez; Claudia Schulte; Manu Sharma; Lynne Krohn; Lasse Pihlstrøm; Ari Siitonen; Hirotaka Iwaki; Hampton Leonard; Faraz Faghri; J Raphael Gibbs; Dena G Hernandez; Sonja W Scholz; Juan A Botia; Maria Martinez; Jean-Christophe Corvol; Suzanne Lesage; Joseph Jankovic; Lisa M Shulman; Margaret Sutherland; Pentti Tienari; Kari Majamaa; Mathias Toft; Ole A Andreassen; Tushar Bangale; Alexis Brice; Jian Yang; Ziv Gan-Or; Thomas Gasser; Peter Heutink; Joshua M Shulman; Nicholas W Wood; David A Hinds; John A Hardy; Huw R Morris; Jacob Gratten; Peter M Visscher; Robert R Graham; Andrew B Singleton
Journal:  Lancet Neurol       Date:  2019-12       Impact factor: 44.182

9.  Association study of DNAJC13, UCHL1, HTRA2, GIGYF2, and EIF4G1 with Parkinson's disease.

Authors:  Prabhjyot Saini; Uladzislau Rudakou; Eric Yu; Jennifer A Ruskey; Farnaz Asayesh; Sandra B Laurent; Dan Spiegelman; Stanley Fahn; Cheryl Waters; Oury Monchi; Yves Dauvilliers; Nicolas Dupré; Lior Greenbaum; Sharon Hassin-Baer; Alberto J Espay; Guy A Rouleau; Roy N Alcalay; Edward A Fon; Ronald B Postuma; Ziv Gan-Or
Journal:  Neurobiol Aging       Date:  2020-10-31       Impact factor: 4.673

10.  Second-generation PLINK: rising to the challenge of larger and richer datasets.

Authors:  Christopher C Chang; Carson C Chow; Laurent Cam Tellier; Shashaank Vattikuti; Shaun M Purcell; James J Lee
Journal:  Gigascience       Date:  2015-02-25       Impact factor: 6.524

View more
  3 in total

1.  Lack of evidence for association of UQCRC1 with autosomal dominant Parkinson's disease in Caucasian families.

Authors:  Thomas Courtin; Christelle Tesson; Jean-Christophe Corvol; Suzanne Lesage; Alexis Brice
Journal:  Neurogenetics       Date:  2021-07-21       Impact factor: 2.660

Review 2.  A genome on shaky ground: exploring the impact of mitochondrial DNA integrity on Parkinson's disease by highlighting the use of cybrid models.

Authors:  Martin Lang; Anne Grünewald; Peter P Pramstaller; Andrew A Hicks; Irene Pichler
Journal:  Cell Mol Life Sci       Date:  2022-05-05       Impact factor: 9.207

Review 3.  Monogenic Parkinson's Disease: Genotype, Phenotype, Pathophysiology, and Genetic Testing.

Authors:  Fangzhi Jia; Avi Fellner; Kishore Raj Kumar
Journal:  Genes (Basel)       Date:  2022-03-07       Impact factor: 4.096

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.